Kim Han Young, Jo Mihee, La Ju A, Choi Youngjin, Cho Eun Chul, Kim Su Hee, Jung Youngmee, Kim Kwangmeyung, Ryu Ju Hee
Department of Biomedical-Chemical Engineering, The Catholic University of Korea, Bucheon 14662, Gyeonggi-do, Korea.
Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul 02792, Korea.
Cancers (Basel). 2021 Sep 8;13(18):4523. doi: 10.3390/cancers13184523.
High LOX levels in the tumor microenvironment causes the cross-linking of extracellular matrix components and increases the stiffness of tumor tissue. Thus, LOX plays an important role in tumorigenesis and in lowering the tumor response to anticancer drugs. Despite comprehensive efforts to identify the roles of LOX in the tumor microenvironment, sensitive and accurate detection methods have not yet been established. Here, we suggest the use of gold nanoparticles functionalized with LOX-sensitive peptides (LS-AuNPs) that aggregate upon exposure to LOX, resulting in a visual color change. LOX-sensitive peptides (LS-peptides) contain lysine residues that are converted to allysine in the presence of LOX, which is highly reactive and binds to adjacent allysine, resulting in the aggregation of the AuNPs. We demonstrated that the synthesized LS-AuNPs are capable of detecting LOX sensitively, specifically both in vitro and in the tissue extract. Moreover, the suggested LS-AuNP-based assay is more sensitive than commonly employed assays or commercially available kits. Therefore, the LS-AuNPs developed in this study can be used to detect LOX levels and can be further used to predict the stiffness or the anticancer drug resistance of the tumor.
肿瘤微环境中高表达的赖氨氧化酶(LOX)会导致细胞外基质成分交联,增加肿瘤组织的硬度。因此,LOX在肿瘤发生以及降低肿瘤对抗癌药物的反应中发挥重要作用。尽管人们为确定LOX在肿瘤微环境中的作用付出了诸多努力,但尚未建立灵敏且准确的检测方法。在此,我们建议使用用LOX敏感肽(LS-AuNPs)功能化的金纳米颗粒,其在暴露于LOX时会聚集,导致颜色发生肉眼可见的变化。LOX敏感肽(LS-肽)含有赖氨酸残基,在LOX存在下会转化为烯赖氨酸,烯赖氨酸具有高反应性并与相邻的烯赖氨酸结合,导致金纳米颗粒聚集。我们证明合成的LS-AuNPs能够在体外和组织提取物中灵敏、特异地检测LOX。此外,所建议的基于LS-AuNP的检测方法比常用检测方法或市售试剂盒更灵敏。因此,本研究中开发的LS-AuNPs可用于检测LOX水平,并可进一步用于预测肿瘤的硬度或抗癌药物耐药性。